Kyle Jenne

Corporate Officer/Principal presso IONIS PHARMACEUTICALS, INC.

Patrimonio netto: 86 223 $ in data 31/03/2024

48 anni

Health Technology

Consumer Services

Profilo

Kyle Jenne is currently the Chief Executive Officer & Director at Elsie Biotechnologies Inc. He is also the Executive Vice President-Commercial at Ionis Pharmaceuticals, Inc. Additionally, Mr. Jenne previously worked as the Chief Commercial Officer & Executive VP at Ionis Pharmaceuticals, Inc. and as the Senior Vice President-US Commercial at Akcea Therapeutics, Inc. He completed his undergraduate degree at Arizona State University.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
IONIS PHARMACEUTICALS, INC. 0.00%	26/02/2024	1 989 ( 0.00% )	86 223 $	31/03/2024

Posizioni attive di Kyle Jenne

Società	Posizione	Inizio
IONIS PHARMACEUTICALS, INC.	Corporate Officer/Principal	29/02/2024
Elsie Biotechnologies Inc. Elsie Biotechnologies Inc. BiotechnologyHealth Technology Elsie Biotechnologies Inc. is a private company located in California that is focused on utilizing RNA therapeutics to treat diseases that were previously considered undruggable. The American company's platform enables the synthesis, deconvolution, and delivery of homogeneous oligonucleotide therapeutics. The company was founded in 2021 by Philip E. Dawson and Phil Baran, and the CEO is Kyle Jenne.	Chief Executive Officer	-

Tutte le posizioni attive di Kyle Jenne

Precedenti posizioni note di Kyle Jenne

Società	Posizione	Fine
IONIS PHARMACEUTICALS, INC.	Corporate Officer/Principal	-
AKCEA THERAPEUTICS, INC.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Kyle Jenne

Formazione di Kyle Jenne

Arizona State University

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kyle Jenne

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
IONIS PHARMACEUTICALS, INC.	Health Technology

Aziende private	2
Akcea Therapeutics, Inc. Akcea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.	Health Technology
Elsie Biotechnologies Inc. Elsie Biotechnologies Inc. BiotechnologyHealth Technology Elsie Biotechnologies Inc. is a private company located in California that is focused on utilizing RNA therapeutics to treat diseases that were previously considered undruggable. The American company's platform enables the synthesis, deconvolution, and delivery of homogeneous oligonucleotide therapeutics. The company was founded in 2021 by Philip E. Dawson and Phil Baran, and the CEO is Kyle Jenne.	Health Technology